Human recombinant erythropoietin (rEpo) has no effect on tumour growth or angiogenesis.

Autor: Hardee, M. E.1, Kirkpatrick, J. P.2, Shan, S.2, Snyder, S. A.2, Vujaskovic, Z.2, Rabbani, Z. N.2, Dewhirst, M. W.2, Blackwell, K. L.2,3 black034@mc.duke.edu
Zdroj: British Journal of Cancer. 12/12/2005, Vol. 93 Issue 12, p1350-1355. 6p. 1 Color Photograph, 1 Diagram, 3 Graphs.
Databáze: Academic Search Ultimate